Ironwood Pharmaceuticals Inc (IRWD)
8.12
-0.18
(-2.17%)
USD |
NASDAQ |
May 03, 16:00
8.115
0.00 (0.00%)
After-Hours: 20:00
Ironwood Pharmaceuticals Cash from Financing (TTM): 277.16M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 277.16M |
September 30, 2023 | 330.87M |
June 30, 2023 | 406.66M |
March 31, 2023 | -142.70M |
December 31, 2022 | -237.55M |
September 30, 2022 | -258.95M |
June 30, 2022 | -253.58M |
March 31, 2022 | -97.63M |
December 31, 2021 | -4.55M |
September 30, 2021 | 17.56M |
June 30, 2021 | 12.07M |
March 31, 2021 | 8.802M |
December 31, 2020 | 18.55M |
September 30, 2020 | 21.47M |
June 30, 2020 | 29.43M |
March 31, 2020 | 19.54M |
December 31, 2019 | -1.185M |
September 30, 2019 | -2.783M |
June 30, 2019 | -3.606M |
March 31, 2019 | 16.02M |
December 31, 2018 | 30.07M |
September 30, 2018 | 31.39M |
June 30, 2018 | 8.667M |
March 31, 2018 | 6.018M |
December 31, 2017 | 19.84M |
Date | Value |
---|---|
September 30, 2017 | 18.85M |
June 30, 2017 | 30.37M |
March 31, 2017 | 18.80M |
December 31, 2016 | -4.176M |
September 30, 2016 | -11.70M |
June 30, 2016 | -12.28M |
March 31, 2016 | 293.78M |
December 31, 2015 | 303.07M |
September 30, 2015 | 312.92M |
June 30, 2015 | 319.36M |
March 31, 2015 | 22.36M |
December 31, 2014 | 210.94M |
September 30, 2014 | 204.64M |
June 30, 2014 | 203.13M |
March 31, 2014 | 337.28M |
December 31, 2013 | 313.58M |
September 30, 2013 | 313.45M |
June 30, 2013 | 312.95M |
March 31, 2013 | 173.17M |
December 31, 2012 | 88.97M |
September 30, 2012 | 88.53M |
June 30, 2012 | 88.62M |
March 31, 2012 | 88.64M |
December 31, 2011 | 3.133M |
September 30, 2011 | 3.255M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-258.95M
Minimum
Sep 2022
406.66M
Maximum
Jun 2023
7.345M
Average
8.802M
Median
Mar 2021
Cash from Financing (TTM) Benchmarks
Societal CDMO Inc (DELISTED) | 2.342M |
Mirum Pharmaceuticals Inc | 336.60M |
Tharimmune Inc | 11.72M |
Kineta Inc | 8.468M |
Moderna Inc | -821.00M |